International Psoriasis Council

Advancing Knowledge. Improving Care.

Wei Li Headshot

Wei

Li

,

MD

West China Hospital, Sichuan University
Chengdu
,
China
Dr. Wei Li is a chief physician in the Department of Dermatology at West China Hospital, Sichuan University. She specializes in diagnosing and treating autoimmune blistering diseases, psoriasis, and psoriatic arthritis. She established the diagnostic system for blistering diseases at West China Hospital and launched the hospital’s multidisciplinary clinic for psoriasis.

Dr. Li is one of the earliest physicians in China to practice biologic therapies for psoriasis. She is committed to the early detection of psoriatic arthritis in psoriasis patients using tools such as self-developed screening questionnaires and high-frequency joint ultrasound. She holds multiple academic roles, including member of the Psoriasis Group of the Chinese Society of Dermatology, co-chair of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) Dermatologist Membership Engagement Committee, and head of the Psoriasis Group of Sichuan Province in China. Dr. Li is involved in medical education through national and international academic exchanges and collaborations.
Last Updated:
06/25/2025

What's New

First-Line Biologics in Psoriasis: Evidence from the BADBIR Cohort Study

In this IPC commentary, Matias Maskin examines evidence from the BADBIR registry demonstrating that first-line biologic therapy in moderate to severe psoriasis leads to faster skin clearance, improved quality of life, and a lower risk of comorbidities. The analysis challenges traditional step-up approaches and supports earlier, patient-centered treatment strategies.

Read More »

Recent Advances in Psoriasis: A Year in Review

In this Take Ten with IPC video, Dr. Leandro Leite discusses the most recent advances in psoriasis over the last year (March 2025 – March 2026). Topics include new guidelines, research, and recent studies.

WATCH NOW

Monday, April 6, 2026